Article · 4 May 2026
ArticlePublished 27 Oct 2023
TRNA-Histidine Guanylyltransferase 1 is a Potential Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and is Associated with Oxidative Stress
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lung adenocarcinoma is a highly aggressive subtype of lung cancer with a high mortality rate, which makes the investigation of novel lung adenocarcinoma therapeutic targets essential. Since oxidative stress has been shown to be a cancer-specific deplete in the lung, which is highly associated with oxidative stress, it is crucial to investigate and assess the clinical value of oxidative stress-related target genes in lung adenocarcinoma. In the current study, we obtained 3170 differentially expressed genes via differential analysis and 1058 oxidative stress-related genes via the molecular signatures database. Upon analyzing their intersection, 207 genes were identified. tRNA-histidine guanylyltransferase 1 like protein, glutathione peroxidase 8, and mitogen-activated protein kinase 3 were identified as lung adenocarcinoma biomarkers using machine learning algorithms. The tumor immune infiltrating analysis revealed that the tRNA-histidine guanylyltransferase 1 like protein gene is associated with the infiltration of regulatory T cells. In addition, the multivariate analysis revealed that elevated tRNA-histidine guanylyltransferase 1 like protein expression is a significant, independent predictor of overall survival. Furthermore, the pan-cancer analysis revealed that elevated tRNA-histidine guanylyltransferase 1 like protein expression is related to a worse prognosis in a variety of cancers. In light of these findings, the identification of tRNA-histidine guanylyltransferase 1 like protein as a novel biological marker may shed light on potential function mechanisms and the impact of the immune microenvironment in lung adenocarcinoma.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Lingyan Zhu”
- BylineArticles whose byline prints “Yuanyuan Qin”
- BylineArticles whose byline prints “Li Li”
- BylineArticles whose byline prints “Wenting Li”
- BylineArticles whose byline prints “Mianhua Wu”